Theradaptive

Theradaptive is proud to announce that we've secured landmark funding from the Maryland Stem Cell Research Fund (MSCRF) to support human clinical trials for our lead product, OsteoAdapt SP. OsteoAdapt SP is currently in Phase I/II clinical studies for transforaminal lumbar interbody spinal fusion (TLIF), offering hope for those battling degenerative disc disease, spondylolisthesis, and retrolisthesis.   Thanks to MSCRF's generous support, we're expanding our OASIS human clinical study to sites in Maryland. This milestone accelerates our mission to provide groundbreaking therapies to patients in need.   Let's continue pushing boundaries in regenerative medicine! 🌟   #Theradaptive #RegenerativeMedicine #ClinicalTrials #MSCRF #OsteoAdaptSP #Innovation #Biotech #HealthcareRevolution Defense Health Agency

Please join us in extending a warm welcome to Dr. Frank Vizesi, Ph.D., who joins Theradaptive as our new Chief Scientific Officer! With nearly 20 years of experience in orthobiologics research, Frank comes to us from Orthofix, where he served as Chief Scientific Officer. In his new role, Frank will be instrumental in driving Theradaptive's mission forward, particularly as we advance our innovative OsteoAdapt SP implant through clinical trials and toward FDA approval. His expertise in spinal fusion and passion for therapeutic advancements align perfectly with our commitment to delivering targeted regenerative therapeutics. We're thrilled to have Frank on board as we continue to revolutionize patient care and tackle unmet medical needs across various disease areas. Please join us in welcoming him to the team! #Theradaptive #RegenerativeTherapeutics #NewHire #InnovationInHealthcare

We are thrilled to share Theradaptive's latest feature in Vet Practice Magazine! Discover how Theradaptive's groundbreaking technology is transforming veterinary care, enabling veterinarians to effectively treat a range of conditions including fractures, torn cranial cruciate ligaments, tooth decay, jaw injuries, cranio-facial injuries, and joint degeneration in animals. This insightful article provides a deep dive into Theradaptive's innovative approach and its significant impact on animal health and well-being. #Theradaptive #VeterinaryCare #AnimalHealth #InnovationInMedicine #VetPracticeMagazine #MedicalTechnology #AnimalWellbeing #StayInformed

Exciting News! Theradaptive is thrilled to announce a major milestone in our journey towards global expansion and bringing innovative solutions to patients worldwide! We are proud to share that the Bellberry Ethics Committee has granted full approval for our clinical trials in Australia for OsteoAdapt SP. This decision marks a pivotal moment for Theradaptive as we accelerate our transition into a clinical-stage organization. As we embark on this transformative journey, we are actively seeking top talent to join our dynamic team. Together, we will shape the future of healthcare and bring OsteoAdapt SP to patients around the world.   Join us in celebrating this milestone and be part of our exciting growth story! Read our press release below for more information #Theradaptive #ClinicalTrials #GlobalExpansion #Innovation #Healthcare #OsteoAdaptSP #SpinalFusion #regenerativemedicine

We’re #hiring a new Jr. Clinical Research Associate in Frederick, Maryland. Apply today or share this post with your network.

We are very excited to share a momentous achievement for Theradaptive: FDA approval to commence human clinical studies. Our journey advances with the initiation of the OASIS study, a groundbreaking Phase I/II examination of the safety and efficacy of OsteoAdapt in TLIF spinal fusion procedures.   This signifies that the remarkable product our team has dedicated extensive time and effort to is now poised for its inaugural use in treating humans. Together, we're staying true to our commitment to bring renewed hope to patients facing limited options. #Theradaptive #MilestoneCelebration #ClinicalTrials #TeamSuccess #HealthcareInnovation #ProteinEngineering #RegenerativeMedicine #SpinalFusion

Check out Dr. Luis Alvarez’s interview with Carolyn at BoneZone, where Theradaptive's incredible journey is highlighted. Learn about our strategic partnership with 3D Systems, the future of regenerative medicine in spinal implants, and our short-term plans, including the upcoming first in-human clinical trials. Read more below! #Theradaptive #RegenerativeMedicine #ClinicalTrials #Innovation

Theradaptive will be at the J.P. Morgan Healthcare Conference in San Francisco this January, and we are excited to connect with you. Meet with us to learn more about our first-in-human clinical trials for our regenerative spinal fusion implant, beginning early 2024, as well as our programs in Dental, Veterinary, and Oncology. Reach out to Serena Lertora (serena.lertora@theradaptive.com) to schedule a meeting at Theradaptive’s location in San Francisco.   #MedicalInnovation #RegenerativeMedicine #SpinalFusion #SeriesB #Theradaptive #HealthcareTech #JPM2024 #ProteinEngineering #Oncology #Orthopedics #Dental #Veterinary 

We’re #hiring a new Director/Assoc Director, Analytical Development in Frederick, Maryland. Apply today or share this post with your network.